Akèy › Anplwayè › Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.: Salè H-1B ak pajon
Kymera Therapeutics, Inc. depoze 15 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 15. Medyèn salè yo ofri a: $135,000.
Èske Kymera Therapeutics, Inc. pajone visa H-1B?
Kymera Therapeutics, Inc. depoze 15 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 22, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Associate Director, Translational Medicine | 2 | $180,000 |
| Senior Research Associate, Platform Biology | 1 | $90,000 |
| Research Associate II, Cellular Assays | 1 | $75,000 |
| Senior Scientist, In Vitro Pharmacology | 1 | $135,000 |
| Associate Scientist, Platform Biology | 1 | $110,000 |
| Senior Scientist, Proteomics | 1 | $140,000 |
| Scientist (Discovery Biology) | 1 | $120,000 |
| Associate Director, Bioanalytical | 1 | $185,000 |
| Principal Scientist, Biological Sciences | 1 | $160,000 |
| Scientist, Computational Biology | 1 | $130,000 |
| Senior Director, Pharmacovigilance Operations | 1 | $280,000 |
| Associate Scientist, Discovery Biology | 1 | $125,715 |
| Associate Scientist, Cellular Pharmacology | 1 | $113,000 |
| Director, Late Stage Formulations Development | 1 | $230,000 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 4 | $112,500 |
| FY2024 | 2 | $125,000 |
| FY2025 | 5 | $160,000 |
| FY2026 | 4 | $177,858 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
- Biochemists and Biophysicists7
- Molecular and Cellular Biologists4
- Medical Scientists, Except Epidemiologists2
- Regulatory Affairs Managers1
- Natural Sciences Managers1
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Director, Late Stage Formulations Development | $230,000 Nivo II | Watertown, MA | Jun 22, 2026 | Jul 6, 2026 | Certifye |
| Associate Scientist, Cellular Pharmacology | $113,000 Nivo I | Watertown, MA | Jun 8, 2026 | Oct 1, 2026 | Certifye |
| Associate Scientist, Discovery Biology | $125,715 Nivo II | Watertown, MA | May 1, 2026 | Oct 1, 2026 | Certifye |
| Senior Director, Pharmacovigilance Operations | $280,000 Nivo IV | Watertown, MA | Mar 10, 2026 | Mar 12, 2026 | Certifye |
| Principal Scientist, Biological Sciences | $160,000–$180,000 Nivo II | Watertown, MA | Aug 20, 2025 | Oct 1, 2025 | Certifye |
| Scientist, Computational Biology | $130,000–$150,000 Nivo II | Watertown, MA | Aug 18, 2025 | Oct 1, 2025 | Certifye |
| Associate Director, Translational Medicine | $190,000–$215,000 Nivo II | Watertown, MA | Aug 1, 2025 | Oct 1, 2025 | Certifye |
| Associate Director, Bioanalytical | $185,000–$210,000 Nivo III | Watertown, MA | Jun 18, 2025 | Jul 21, 2025 | Certifye |
| Scientist (Discovery Biology) | $120,000–$140,000 Nivo II | Watertown, MA | Mar 12, 2025 | May 9, 2025 | Certifye |
| Senior Scientist, Proteomics | $140,000–$160,000 Nivo III | Watertown, MA | Apr 8, 2024 | Oct 1, 2024 | Certifye |
| Associate Scientist, Platform Biology | $110,000–$130,000 Nivo II | Watertown, MA | Dec 12, 2023 | Apr 30, 2024 | Certifye |
| Senior Scientist, In Vitro Pharmacology | $135,000–$155,000 Nivo III | Watertown, MA | Aug 7, 2023 | Aug 28, 2023 | Certifye |
| Research Associate II, Cellular Assays | $75,000–$90,000 Nivo I | Watertown, MA | May 8, 2023 | Oct 1, 2023 | Certifye |
| Senior Research Associate, Platform Biology | $90,000–$110,000 Nivo I | Watertown, MA | May 8, 2023 | Oct 1, 2023 | Certifye |
| Associate Director, Translational Medicine | $170,000–$190,000 Nivo II | Watertown, MA | Oct 3, 2022 | Oct 24, 2022 | Certifye |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).